I’ve been keeping an eye on The Clorox Company (NYSE:CLX) because I’m attracted to its fundamentals. Looking at the company as a whole, as a potential stock investment, I believe CLX has a lot to offer. Basically, it is a dependable dividend payer that has been able to sustain great financial health over the past. Below, I’ve touched on some key aspects you should know on a high level. For those interested in understanding where the figures come from and want to see the analysis, take a look at the report on Clorox here.
Established dividend payer with adequate balance sheet
CLX’s strong financial health means that all of its upcoming liability payments are able to be met by its current cash and short-term investment holdings. This suggests prudent control over cash and cost by management, which is an important determinant of the company’s health. CLX appears to have made good use of debt, producing operating cash levels of 0.38x total debt in the prior year. This is a strong indication that debt is reasonably met with cash generated.
Income investors would also be happy to know that CLX is a great dividend company, with a current yield standing at 2.6%. CLX has also been regularly increasing its dividend payments to shareholders over the past decade.
For Clorox, there are three pertinent factors you should further examine:
- Future Outlook: What are well-informed industry analysts predicting for CLX’s future growth? Take a look at our free research report of analyst consensus for CLX’s outlook.
- Historical Performance: What has CLX’s returns been like over the past? Go into more detail in the past track record analysis and take a look at the free visual representations of our analysis for more clarity.
- Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of CLX? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
If you spot an error that warrants correction, please contact the editor at firstname.lastname@example.org. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.